Nordic Nanovector ASA: Financial Calendar for 2022

OSLO, Norway, Dec. 23, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces its Financial Calendar for 2022. Q4 and FY 2021 Results: Thursday 17 February...